{"id":{"repo_id":"bu","oai_identifier":"oai:open.bu.edu:2144/53795"},"canonical_url":"https://search.ndltd.org/etd/bu/oai:open.bu.edu:2144/53795","repository":{"repo_id":"bu","name":"Boston University","base_url":"https://open.bu.edu/oai/request"},"display":{"title":"The effects of dairy-related exposures on lipoprotein(a) and other cardiometabolic risk factors","abstract":"Background: Cardiovascular disease (CVD) remains the leading cause of death globally. CVD is influenced by several risk factors such as dyslipidemia, high blood pressure, and impaired glucose tolerance or diabetes. Lipoprotein(a) [Lp(a)] is a highly genetically determined independent risk factor for atherosclerotic cardiovascular disease (ASCVD), and one in five people is at high risk due to elevated Lp(a). Evidence is accumulating that diet may modulate Lp(a) levels. There is also evidence that certain subtypes of high-fat dairy can have beneficial cardiometabolic effects. The extent to which dairy fats or eating patterns high in dairy fat affect lipid and cardiometabolic biomarkers such as Lp(a) remains unknown. Objectives: This prospective cohort study aims to examine the association between dairy exposures and Lp(a), as well as other traditional cardiometabolic risk (CMR) factors. We specifically evaluate the combined effects of dairy and Lp(a) on other cardiometabolic risk factors and CVD. We hypothesize that a higher intake of total dairy and full-fat dairy are associated with more favorable outcomes. Methods: Participants included in the analysis were from the Framingham Offspring Study (FOS) with valid dietary data, aged 30 or older, with no prevalent cancer or cardiovascular disease at or before baseline. Outcomes include CMR factors: Lp(a), LDL, HDL, triglycerides, lipid particle size and concentration (LDL, HDL, VLDL), fibrinogen, apolipoprotein A and B, IL-6, and Factor VII were collected at the first available exam after or at the same time as the dietary assessment (via food records) at exams 3 and 5. Logistic regression and ANCOVA models were used to estimate odds ratios for elevated Lp(a) risk and adjusted mean levels of CMR factors across intake categories of dairy exposures in FOS. Cox proportional hazard models were used to assess risk of CVD. All models were adjusted for age and sex. Potential confounders were assessed based on their impact and retained. Results: Among FOS participants, higher total dairy and whole fat dairy were associated with HDL-C, Log-TG, TG:HDL, Apo A-1 and ApoB, HDL-P, Log-VLDL-P, HDL size, and LDL size in males only, all in favorable directions (P≤0.05). Higher total dairy intake was associated with lower odds of elevated Lp(a) (OR: 0.59, 95% CI: 0.37–0.94 for >2 vs. <0.5 cup-eq/day, p-trend=0.073),). Lp(a) was positively associated with LDL-C, ApoB, and Log Fibrinogen in males, and with LDL-C and Log Fibrinogen in females. Full-fat dairy intake combined with moderate Lp(a) levels was associated with a significant reduction in incident CVD risk (HR: 0.65, 95% CI: 0.45–0.94 and HR: 0.68, 95% CI: 0.48–0.95 for low and high full-fat dairy, respectively), independent of traditional CVD risk factors. Conclusion: We found no evidence to support an adverse relationship between dairy fats and several cardiometabolic risk factors. These findings suggest that fat in dairy products may not negatively influence cardiometabolic health and are even positively associated with lipid profiles in males.","abstract_html":"Background: Cardiovascular disease (CVD) remains the leading cause of death globally. CVD is influenced by several risk factors such as dyslipidemia, high blood pressure, and impaired glucose tolerance or diabetes. Lipoprotein(a) [Lp(a)] is a highly genetically determined independent risk factor for atherosclerotic cardiovascular disease (ASCVD), and one in five people is at high risk due to elevated Lp(a). Evidence is accumulating that diet may modulate Lp(a) levels. There is also evidence that certain subtypes of high-fat dairy can have beneficial cardiometabolic effects. The extent to which dairy fats or eating patterns high in dairy fat affect lipid and cardiometabolic biomarkers such as Lp(a) remains unknown. Objectives: This prospective cohort study aims to examine the association between dairy exposures and Lp(a), as well as other traditional cardiometabolic risk (CMR) factors. We specifically evaluate the combined effects of dairy and Lp(a) on other cardiometabolic risk factors and CVD. We hypothesize that a higher intake of total dairy and full-fat dairy are associated with more favorable outcomes. Methods: Participants included in the analysis were from the Framingham Offspring Study (FOS) with valid dietary data, aged 30 or older, with no prevalent cancer or cardiovascular disease at or before baseline. Outcomes include CMR factors: Lp(a), LDL, HDL, triglycerides, lipid particle size and concentration (LDL, HDL, VLDL), fibrinogen, apolipoprotein A and B, IL-6, and Factor VII were collected at the first available exam after or at the same time as the dietary assessment (via food records) at exams 3 and 5. Logistic regression and ANCOVA models were used to estimate odds ratios for elevated Lp(a) risk and adjusted mean levels of CMR factors across intake categories of dairy exposures in FOS. Cox proportional hazard models were used to assess risk of CVD. All models were adjusted for age and sex. Potential confounders were assessed based on their impact and retained. Results: Among FOS participants, higher total dairy and whole fat dairy were associated with HDL-C, Log-TG, TG:HDL, Apo A-1 and ApoB, HDL-P, Log-VLDL-P, HDL size, and LDL size in males only, all in favorable directions (P≤0.05). Higher total dairy intake was associated with lower odds of elevated Lp(a) (OR: 0.59, 95% CI: 0.37–0.94 for &gt;2 vs. &lt;0.5 cup-eq/day, p-trend=0.073),). Lp(a) was positively associated with LDL-C, ApoB, and Log Fibrinogen in males, and with LDL-C and Log Fibrinogen in females. Full-fat dairy intake combined with moderate Lp(a) levels was associated with a significant reduction in incident CVD risk (HR: 0.65, 95% CI: 0.45–0.94 and HR: 0.68, 95% CI: 0.48–0.95 for low and high full-fat dairy, respectively), independent of traditional CVD risk factors. Conclusion: We found no evidence to support an adverse relationship between dairy fats and several cardiometabolic risk factors. These findings suggest that fat in dairy products may not negatively influence cardiometabolic health and are even positively associated with lipid profiles in males.","abstract_has_math":false,"creators":["Vander Mark, Esther"],"institution":"Boston University","degree_name":"Master of Science","degree_level":"masters","degree_discipline":"Nutrition and Metabolism","degree_department":null,"school":null,"contributors":[],"advisors":["Moore, Lynn L."],"committee_chairs":[],"committee_members":[],"year":2026,"date_issued":"2026","date_published":"2026","updated_at":"2026-11-18T20:25:51Z","subjects":["Nutrition"],"languages":["en_US"],"rights":[],"rights_urls":[],"identifier_entries":[],"person_identifier_entries":[]},"links":{"outbound_url":"https://hdl.handle.net/2144/53795","outbound_label":"Handle","outbound_source":"dc:identifier.uri","record_url":"https://hdl.handle.net/2144/53795","record_label":"Repository record","record_kind":"handle","record_source":"dc:identifier.uri","download_url":null,"download_label":null,"download_source":null,"access_status":null,"embargo_until":null,"access_note":null},"source_record":{"url":"https://open.bu.edu/oai/request?verb=GetRecord&metadataPrefix=dim&identifier=oai%3Aopen.bu.edu%3A2144%2F53795","prefix":"dim"},"metadata_groups":[{"id":"people","label":"People","entries":[{"key":"dc:contributor.advisor","label":"Advisor","values":["Moore, Lynn L."]},{"key":"dc:creator","label":"Author","values":["Vander Mark, Esther"]}]},{"id":"academic_context","label":"Academic Context","entries":[{"key":"dc:date.accessioned","label":"Dc Date Accessioned","values":["2026-10-23T15:39:25Z"]},{"key":"dc:date.available","label":"Dc Date Available","values":["2026-10-23T15:39:25Z"]},{"key":"dc:date.issued","label":"Date","values":["2026"]},{"key":"dc:date.updated","label":"Dc Date Updated","values":["2026-08-26T16:17:59Z"]},{"key":"dc:type","label":"Dc Type","values":["Thesis/Dissertation"]},{"key":"thesis:degree_discipline","label":"Discipline","values":["Nutrition and Metabolism"]},{"key":"thesis:degree_level","label":"Degree Level","values":["masters"]},{"key":"thesis:degree_name","label":"Degree Name","values":["Master of Science"]},{"key":"thesis:institution_name","label":"Thesis Institution Name","values":["Boston University"]}]},{"id":"subjects_keywords","label":"Subjects and Keywords","entries":[{"key":"dc:subject","label":"Dc Subject","values":["Nutrition"]}]},{"id":"language_rights","label":"Language and Rights","entries":[{"key":"dc:language.iso","label":"Language (ISO)","values":["en_US"]}]},{"id":"identifiers","label":"Identifiers","entries":[{"key":"dc:identifier.uri","label":"Identifier URI","values":["https://hdl.handle.net/2144/53795"]}]},{"id":"additional","label":"Additional Metadata","entries":[{"key":"dc:description","label":"Description","values":["2026"]},{"key":"dc:description.abstract","label":"Abstract","values":["Background: Cardiovascular disease (CVD) remains the leading cause of death globally. CVD is influenced by several risk factors such as dyslipidemia, high blood pressure, and impaired glucose tolerance or diabetes. Lipoprotein(a) [Lp(a)] is a highly genetically determined independent risk factor for atherosclerotic cardiovascular disease (ASCVD), and one in five people is at high risk due to elevated Lp(a). Evidence is accumulating that diet may modulate Lp(a) levels. There is also evidence that certain subtypes of high-fat dairy can have beneficial cardiometabolic effects. The extent to which dairy fats or eating patterns high in dairy fat affect lipid and cardiometabolic biomarkers such as Lp(a) remains unknown. Objectives: This prospective cohort study aims to examine the association between dairy exposures and Lp(a), as well as other traditional cardiometabolic risk (CMR) factors. We specifically evaluate the combined effects of dairy and Lp(a) on other cardiometabolic risk factors and CVD. We hypothesize that a higher intake of total dairy and full-fat dairy are associated with more favorable outcomes. Methods: Participants included in the analysis were from the Framingham Offspring Study (FOS) with valid dietary data, aged 30 or older, with no prevalent cancer or cardiovascular disease at or before baseline. Outcomes include CMR factors: Lp(a), LDL, HDL, triglycerides, lipid particle size and concentration (LDL, HDL, VLDL), fibrinogen, apolipoprotein A and B, IL-6, and Factor VII were collected at the first available exam after or at the same time as the dietary assessment (via food records) at exams 3 and 5. Logistic regression and ANCOVA models were used to estimate odds ratios for elevated Lp(a) risk and adjusted mean levels of CMR factors across intake categories of dairy exposures in FOS. Cox proportional hazard models were used to assess risk of CVD. All models were adjusted for age and sex. Potential confounders were assessed based on their impact and retained. Results: Among FOS participants, higher total dairy and whole fat dairy were associated with HDL-C, Log-TG, TG:HDL, Apo A-1 and ApoB, HDL-P, Log-VLDL-P, HDL size, and LDL size in males only, all in favorable directions (P≤0.05). Higher total dairy intake was associated with lower odds of elevated Lp(a) (OR: 0.59, 95% CI: 0.37–0.94 for >2 vs. <0.5 cup-eq/day, p-trend=0.073),). Lp(a) was positively associated with LDL-C, ApoB, and Log Fibrinogen in males, and with LDL-C and Log Fibrinogen in females. Full-fat dairy intake combined with moderate Lp(a) levels was associated with a significant reduction in incident CVD risk (HR: 0.65, 95% CI: 0.45–0.94 and HR: 0.68, 95% CI: 0.48–0.95 for low and high full-fat dairy, respectively), independent of traditional CVD risk factors. Conclusion: We found no evidence to support an adverse relationship between dairy fats and several cardiometabolic risk factors. These findings suggest that fat in dairy products may not negatively influence cardiometabolic health and are even positively associated with lipid profiles in males."]},{"key":"dc:title","label":"Title","values":["The effects of dairy-related exposures on lipoprotein(a) and other cardiometabolic risk factors"]}]}],"canonical_facts":{"dc:contributor.advisor":["Moore, Lynn L."],"dc:creator":["Vander Mark, Esther"],"dc:date.accessioned":["2026-10-23T15:39:25Z"],"dc:date.available":["2026-10-23T15:39:25Z"],"dc:date.issued":["2026"],"dc:date.updated":["2026-08-26T16:17:59Z"],"dc:description":["2026"],"dc:description.abstract":["Background: Cardiovascular disease (CVD) remains the leading cause of death globally. CVD is influenced by several risk factors such as dyslipidemia, high blood pressure, and impaired glucose tolerance or diabetes. Lipoprotein(a) [Lp(a)] is a highly genetically determined independent risk factor for atherosclerotic cardiovascular disease (ASCVD), and one in five people is at high risk due to elevated Lp(a). Evidence is accumulating that diet may modulate Lp(a) levels. There is also evidence that certain subtypes of high-fat dairy can have beneficial cardiometabolic effects. The extent to which dairy fats or eating patterns high in dairy fat affect lipid and cardiometabolic biomarkers such as Lp(a) remains unknown. Objectives: This prospective cohort study aims to examine the association between dairy exposures and Lp(a), as well as other traditional cardiometabolic risk (CMR) factors. We specifically evaluate the combined effects of dairy and Lp(a) on other cardiometabolic risk factors and CVD. We hypothesize that a higher intake of total dairy and full-fat dairy are associated with more favorable outcomes. Methods: Participants included in the analysis were from the Framingham Offspring Study (FOS) with valid dietary data, aged 30 or older, with no prevalent cancer or cardiovascular disease at or before baseline. Outcomes include CMR factors: Lp(a), LDL, HDL, triglycerides, lipid particle size and concentration (LDL, HDL, VLDL), fibrinogen, apolipoprotein A and B, IL-6, and Factor VII were collected at the first available exam after or at the same time as the dietary assessment (via food records) at exams 3 and 5. Logistic regression and ANCOVA models were used to estimate odds ratios for elevated Lp(a) risk and adjusted mean levels of CMR factors across intake categories of dairy exposures in FOS. Cox proportional hazard models were used to assess risk of CVD. All models were adjusted for age and sex. Potential confounders were assessed based on their impact and retained. Results: Among FOS participants, higher total dairy and whole fat dairy were associated with HDL-C, Log-TG, TG:HDL, Apo A-1 and ApoB, HDL-P, Log-VLDL-P, HDL size, and LDL size in males only, all in favorable directions (P≤0.05). Higher total dairy intake was associated with lower odds of elevated Lp(a) (OR: 0.59, 95% CI: 0.37–0.94 for >2 vs. <0.5 cup-eq/day, p-trend=0.073),). Lp(a) was positively associated with LDL-C, ApoB, and Log Fibrinogen in males, and with LDL-C and Log Fibrinogen in females. Full-fat dairy intake combined with moderate Lp(a) levels was associated with a significant reduction in incident CVD risk (HR: 0.65, 95% CI: 0.45–0.94 and HR: 0.68, 95% CI: 0.48–0.95 for low and high full-fat dairy, respectively), independent of traditional CVD risk factors. Conclusion: We found no evidence to support an adverse relationship between dairy fats and several cardiometabolic risk factors. These findings suggest that fat in dairy products may not negatively influence cardiometabolic health and are even positively associated with lipid profiles in males."],"dc:identifier.uri":["https://hdl.handle.net/2144/53795"],"dc:language.iso":["en_US"],"dc:subject":["Nutrition"],"dc:title":["The effects of dairy-related exposures on lipoprotein(a) and other cardiometabolic risk factors"],"dc:type":["Thesis/Dissertation"],"thesis:degree_discipline":["Nutrition and Metabolism"],"thesis:degree_level":["masters"],"thesis:degree_name":["Master of Science"],"thesis:institution_name":["Boston University"]},"updated_at":"2026-11-18T20:25:51Z"}